Researchers at the University of East Anglia have developed a new nanoparticle-based cancer therapy to deliver a combination therapy directly to cancer cells.
The new therapy, which has been demonstrated to make prostate cancer and breast cancer tumors more sensitive to chemotherapy, is currently close to entering clinical trials.
Researchers at UEA’s Norwich Medical School have established that it can be mass-produced, making it a practical treatment if ascertained as effective in human trials.
Using nanoparticles to send the drugs straight into a tumor is a growing area of cancer study. The technology created at UEA is the first of its kind to use nanoparticles to transport two drugs in combination to target cancer cells.
The drugs, already permitted for clinical use, are an anti-cancer drug known as docetaxel, and fingolimod, a multiple sclerosis drug that renders tumors more sensitive to chemotherapy.
Fingolimod cannot presently be used in cancer treatment as it also overpowers the immune system, leaving patients with seriously low levels of white blood cells.
While docetaxel is used to treat a number of cancers, mainly breast, stomach, prostate, head, and neck, and a few types of lung cancers, its poisonousness can also result in severe side effects for patients whose tumors are chemo-resistant.
Since the nanoparticles created by the UEA team can deliver the drugs straight to the tumor site, these risks are greatly lowered. Furthermore, the targeted approach means less of the drug is required to destroy the cancer cells.
Image Credit: University of East Anglia
News This Week
Frank Boehm contributes to ‘Immune Aspects of Biopharmaceuticals and Nanomedicines’ – CRC Press
Immune Aspects of Biopharmaceuticals and Nanomedicines 1st Edition Raj Bawa, Janos Szebeni, Thomas J Webster, Gerald F. Audette The enormous advances in the immunology of biotherapeutics and nanomedicines in the past two decades have [...]
Safety Panel Fears Soyuz Failure Could Exacerbate Commercial Crew Safety Concerns
LAS CRUCES, N.M. — Members of an independent NASA safety panel said they were worried that the Oct. 11 Soyuz launch failure could make safety concerns with the agency's commercial crew program even worse. [...]
Canadian astronaut says human space travel will advance ‘sooner than you think’
Canadian astronaut Col. Chris Hadfield (Ret.) on Friday said that human travel to space will happen sooner than we think, adding that the first destination will likely be a return trip to the moon. [...]
Ultrasmall targeted nanoparticles with engineered antibody fragments as an anti-cancer weapon
Antibody-based imaging of a particularly aggressive form of breast cancer is undergoing clinical trials worldwide, but the path from trial to application is being hampered by a major obstacle: safety. Concerns stem from inefficient [...]
New Method Allows Harvesting of 2D Materials in Minutes
Following the discovery of graphene in 2003, there has been considerable interest in other types of 2D materials. However, splitting a bulk crystal material into 2D flakes for use in electronics has proven hard [...]
Cybersecurity isn’t being taken seriously enough: MIT professor
The digital economy is set to unlock tremendous economic value for countries over time. But a common setback for the use of various new technologies is their vulnerability to hackers. That's because companies and [...]
Other published works by Frank Boehm
Frank Boehm (NanoApps Medical CEO) and Angelika Domschke contributed the chapter : “Application of a Conceptual Nanomedical Platform to Facilitate the Mapping of the Human Brain: Survey of Cognitive Functions and Implications”. The book [...]
Nanomedical Device and Systems Design: Challenges, Possibilities, Visions now available to rent on Kindle
To accommodate students who wish to read the book at an affordable cost, Nanomedical Device and Systems Design: Challenges, Possibilities, Visions by Frank Boehm (CEO NanoApps Medical Inc.) is available to rent on Kindle. This book benefits [...]
Why Cyber-Criminals Are Attacking Healthcare — And How To Stop Them
The last five years has seen a surge of attacks on the healthcare industry, with the largest breaches impacting as many as 80 million people. In July this year, it was revealed that 150,000 [...]
A new era in the quest for dark matter
Since the 1970s, astronomers and physicists have been gathering evidence for the presence in the universe of dark matter: a mysterious substance that manifests itself through its gravitational pull. However, despite much effort, none [...]
The Largest Event on Graphene Nanotubes is Open to the Public for the First Time
The Nanoaugmented Materials Industry Summit (NAUM) 2018 in Shanghai on October 31 will gather the world’s leading companies who use and apply graphene nanotubes to share exciting results. This year the event is opening [...]
Simulations show new phenomenon with nanopore DNA sequencing
Any truck operator knows that hydraulics do the heavy lifting. Water does the work because it's nearly incompressible at normal scales. But things behave strangely in nanotechnology, the control of materials at the scale [...]
A human enzyme can biodegrade graphene
Myeloperoxidase - an enzyme naturally found in our lungs - can biodegrade pristine graphene, according to the latest discovery of Graphene Flagship partners in CNRS, University of Strasbourg (France), Karolinska Institute (Sweden) and University [...]
A new weapon in the battle against cancer – Artificial Intelligence
In today’s hospitals and healthcare clinics, a new doctor’s new assistant is now often on the job — in the form of artificial intelligence. Whether it’s analyzing medical images or guiding robots that assist [...]
Healthcare Cybersecurity Is a Top 2019 Executive Challenge
Healthcare cybersecurity will be one of the top 10 challenges, issues, and/or opportunities facing healthcare executives next year, according to a new poll by the Healthcare Executive Group (HCEG). Healthcare cybersecurity covers such issues [...]
Nanotherapy offers hope in treating drug-resistant renal cell carcinoma
A research team has developed a nano-platform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma. Drug resistance to chemotherapy is a significant clinical and financial [...]
Leave A Comment